Shape Therapeutics
Signal active
Organization
Contact Information
Overview
Shape Therapeutics (ShapeTX) is a biotechnology company with an end-to-end approach to RNA Gene Therapy, potentially enabling the development of cures in neurodegenerative, metabolic and rare genetic diseases through our breakthrough payload, delivery, and manufacturing platform technologies. Our vision is to facilitate adoption of these technologies throughout the industry to develop effective treatments for as many patients as possible.
About
Industries
Biotechnology
Founded
2018
Employees
101-250
Headquarters locations
United States, North America
Social
N/A
Profile Resume
Shape Therapeutics headquartered in United States, North America, operates in the Biotechnology sector. The company focuses on Biotechnology and has secured $1.2B in funding across 8 round(s). With a team of 101-250 employees, Shape Therapeutics is actively contributing to advancements in Biotechnology. Their latest funding round, Series B - Shape Therapeutics, raised $112.0M. Discover more about their projects, partnerships, and impact on our platform.
Funding Rounds
Funding rounds
2
Investors
6
Lead Investors
0
Total Funding Amount
$147.5M
Details
2
Shape Therapeutics has raised a total of $147.5M in funding over 2 rounds.
| Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
|---|---|---|---|---|
| 2019 | Early Stage Venture | 35.5M | ||
| 2021 | Early Stage Venture | 112.0M |
Investors
Shape Therapeutics is funded by 16 investors.
| Investor Name | Lead Investor | Funding Round | Partners |
|---|---|---|---|
| Decheng Capital | - | FUNDING ROUND - Decheng Capital | 112.0M |
| New Enterprise Associates | - | FUNDING ROUND - New Enterprise Associates | 112.0M |
| Shape Therapeutics | - | FUNDING ROUND - Shape Therapeutics | 112.0M |
| Ling Wong | - | FUNDING ROUND - Ling Wong | 112.0M |
Recent Activity
There is no recent news or activity for this profile.